No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr19:55691200-55718200 |
Weak transcription |
Right Atrium |
heart
|
2 |
chr19:55691600-55718200 |
Weak transcription |
Placenta Amnion |
Placenta Amnion
|
3 |
chr19:55691800-55717600 |
Strong transcription |
Fetal Intestine Small |
intestine
|
4 |
chr19:55692000-55707800 |
Weak transcription |
K562 |
blood
|
5 |
chr19:55692200-55710000 |
Weak transcription |
Pancreas |
Pancrea
|
6 |
chr19:55692600-55701200 |
Strong transcription |
Fetal Adrenal Gland |
Adrenal Gland
|
7 |
chr19:55692600-55717000 |
Strong transcription |
Duodenum Mucosa |
Duodenum
|
8 |
chr19:55693000-55702800 |
Weak transcription |
Fetal Intestine Large |
intestine
|
9 |
chr19:55694600-55702200 |
Weak transcription |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
10 |
chr19:55696400-55702600 |
Weak transcription |
Rectal Mucosa Donor 31 |
rectum
|
11 |
chr19:55697200-55705000 |
Weak transcription |
Sigmoid Colon |
Sigmoid Colon
|
12 |
chr19:55697400-55702600 |
Weak transcription |
Gastric |
stomach
|
13 |
chr19:55697600-55705000 |
Weak transcription |
HepG2 |
liver
|
14 |
chr19:55697600-55708200 |
Weak transcription |
Stomach Mucosa |
stomach
|
15 |
chr19:55698000-55705000 |
Weak transcription |
Colonic Mucosa |
Colon
|
16 |
chr19:55698200-55702600 |
Weak transcription |
Rectal Mucosa Donor 29 |
rectum
|
17 |
chr19:55699000-55700800 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
18 |
chr19:55699600-55701000 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
19 |
chr19:55699800-55700600 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
20 |
chr19:55699800-55700800 |
Enhancers |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
21 |
chr19:55700000-55700400 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
22 |
chr19:55700000-55700400 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
23 |
chr19:55700000-55700400 |
Flanking Active TSS |
Primary hematopoietic stem cells |
blood
|
24 |
chr19:55700000-55700400 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|
25 |
chr19:55700000-55700400 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
26 |
chr19:55700000-55700600 |
Flanking Active TSS |
NHEK |
skin
|
27 |
chr19:55700000-55701000 |
Enhancers |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
28 |
chr19:55700000-55701200 |
Enhancers |
Spleen |
Spleen
|
29 |
chr19:55700000-55701400 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
30 |
chr19:55700000-55701400 |
Flanking Active TSS |
Hela-S3 |
cervix
|
31 |
chr19:55700000-55701400 |
Enhancers |
HMEC |
breast
|
32 |
chr19:55700000-55701400 |
Enhancers |
HUVEC |
blood vessel
|
33 |
chr19:55700200-55700400 |
Flanking Active TSS |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
34 |
chr19:55700200-55700400 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
35 |
chr19:55700200-55700400 |
Flanking Active TSS |
A549 |
lung
|
36 |
chr19:55700200-55700400 |
Flanking Active TSS |
Osteobl |
bone
|
37 |
chr19:55700200-55700800 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
38 |
chr19:55700200-55700800 |
Enhancers |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
39 |
chr19:55700200-55701200 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
40 |
chr19:55700200-55701400 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
41 |
chr19:55700200-55701400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|